Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 29.55%5.71B | 87.98%4.41B | 125.46%1.38B | 57.02%999.05M | 105.88%1.16B | 63.34%877.89M | -3.23%2.35B | 4.52%610.72M | 1.29%636.25M | -8.17%561.84M |
| Cost of revenue | 35.63%3.98B | 66.05%2.94B | 88.16%931.35M | 35.37%639.56M | 77.67%724.08M | 63.05%641.04M | 2.14%1.77B | 16.53%494.98M | 5.94%472.45M | -3.50%407.54M |
| Gross profit | 17.46%1.73B | 155.04%1.47B | 284.96%445.55M | 119.47%359.5M | 180.36%432.61M | 64.14%236.85M | -16.62%578.15M | -27.46%115.74M | -10.10%163.8M | -18.57%154.3M |
| Operating expense | 24.92%1.79B | 69.36%1.44B | 48.22%426.73M | 44.26%328.88M | 108.98%370.54M | 100.25%309.83M | 51.38%847.9M | 82.63%287.89M | 54.56%227.98M | 34.56%177.31M |
| Operating profit | -260.48%-61.85M | 114.29%38.54M | 110.93%18.82M | 147.70%30.61M | 369.85%62.07M | -599.90%-72.97M | -302.44%-269.76M | -9,066.20%-172.15M | -284.91%-64.18M | -139.85%-23M |
| Net non-operating interest income (expenses) | -38.68%-32.16M | -845.72%-23.19M | -444.96%-6.16M | -1,342.79%-5.8M | -1,032.54%-4.77M | -1,195.19%-6.46M | 73.31%-2.45M | 30.16%-1.13M | 93.79%-402K | 40.37%-421K |
| Non-operating interest income | 68.40%3.54M | 10,957.89%2.1M | 12,300.00%620K | 24,550.00%493K | 6,087.50%495K | 12,225.00%493K | 5.56%19K | -54.55%5K | 0.00%2K | 100.00%8K |
| Non-operating interest expense | 30.97%29.28M | 1,036.40%22.35M | 897.15%6.29M | 1,178.22%5.16M | 1,126.81%5.26M | 1,020.08%5.63M | 24.26%1.97M | 64.32%631K | -10.02%404K | 18.51%429K |
| Total other finance cost | 118.59%6.42M | 482.74%2.94M | --486K | --1.13M | --0 | --1.32M | -93.39%504K | ---- | ---- | ---- |
| Net investment income | 4.49M | 1.47M | 0 | 0 | 3.03M | |||||
| Gain(Loss) on financial instruments designated as cash flow hedges | 0 | 1.88M | 0 | -1.21M | -588K | 3.68M | 0 | 0 | 0 | 0 |
| Gain(Loss) on derecognition of available-for-sale financial assets | 229.07%50.03M | 75.77%-38.76M | 70.68%-46.91M | -16.83M | 17.17M | 7.81M | -160M | -160M | 0 | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -93.37%-222.51M | 67.28%-115.07M | -34,665.93%-110.21M | 0 | 0 | -1,675.55%-4.87M | -3,462.43%-351.72M | 87.33%-317K | 0 | -351.13M |
| Less:Other special charges | -1,426.11%-77.96M | -77.84%5.88M | --1.01M | --0 | --0 | 1,675.55%4.87M | 254.00%26.53M | --0 | --0 | --26.26M |
| Less:Write off | 175.18%300.48M | -66.42%109.19M | 34,346.06%109.19M | --0 | ---- | ---- | 13,569.19%325.19M | -86.68%317K | --0 | ---- |
| Other non-operating income (expenses) | -34.47%16.81M | 243.00%25.66M | 103.82%832K | -33.56%196K | -597.61%-9.56M | 2,013.35%34.19M | -118.44%-17.94M | -4,917.97%-21.78M | 104.99%295K | 138.76%1.92M |
| Income before tax | -134.55%-249.68M | 86.72%-106.45M | 60.00%-142.15M | 110.84%6.97M | 117.26%64.32M | -271.45%-35.59M | -856.63%-801.87M | -13,397.04%-355.38M | -530.05%-64.28M | -815.74%-372.63M |
| Income tax | 151.43%94.32M | -882.35%-183.41M | -17,733.37%-177.04M | -261.62%-5.48M | -47.74%9.63M | -1,816.64%-10.52M | 468.37%23.44M | 105.38%1M | 0.59%3.39M | 363.57%18.44M |
| Net income | -547.01%-344M | 109.32%76.96M | 109.79%34.89M | 118.39%12.45M | 113.98%54.69M | -145.87%-25.07M | -834.63%-825.32M | -2,323.63%-356.38M | -684.45%-67.67M | -913.28%-391.07M |
| Net income continuous operations | -547.00%-344M | 109.32%76.96M | 109.79%34.89M | 118.39%12.45M | 113.98%54.69M | -145.89%-25.07M | -834.64%-825.32M | -2,323.77%-356.38M | -684.51%-67.67M | -913.28%-391.07M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -547.01%-344M | 109.32%76.96M | 109.79%34.89M | 118.39%12.45M | 113.98%54.69M | -145.87%-25.07M | -834.63%-825.32M | -2,323.63%-356.38M | -684.45%-67.67M | -913.28%-391.07M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -547.01%-344M | 109.32%76.96M | 109.79%34.89M | 118.39%12.45M | 113.98%54.69M | -145.87%-25.07M | -834.63%-825.32M | -2,323.63%-356.38M | -684.45%-67.67M | -913.28%-391.07M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -495.22%-41.3 | 108.81%10.45 | 109.22%4.72 | 117.25%1.68 | 113.33%7.5 | -134.69%-3.45 | -779.28%-118.67 | -2,549.28%-51.19 | -632.24%-9.74 | -802.94%-56.27 |
| Diluted earnings per share | -502.14%-41.3 | 108.65%10.27 | 109.06%4.64 | 117.04%1.66 | 113.16%7.4087 | -134.69%-3.45 | -809.75%-118.67 | -2,549.28%-51.19 | -676.06%-9.74 | -901.49%-56.2767 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |